Microscale oxygraphy reveals OXPHOS impairment in MRC mutant cells.

Area of Science:

• Biochemistry
• Cellular Biology
• Mitochondrial Medicine

Background:

• Oxidative phosphorylation (OXPHOS) defects are complex to diagnose due to challenges in respiratory chain structure, assembly, and regulation.
• Traditional spectrophotometric assays for respiratory complex activity are specific but require substantial biological material and lack sensitivity.
• Tissue specificity limits the detection of OXPHOS defects in cultured fibroblasts compared to muscle or liver tissue.

Purpose of the Study:

• To establish experimental protocols for direct readout of cellular respiration in patient-derived fibroblast cell lines.
• To evaluate the utility of the Seahorse XF96 apparatus for sensitive and efficient screening of OXPHOS deficiencies.
• To compare the efficacy of microscale oxygraphy with traditional spectrophotometry for biochemical evaluation of mitochondrial disorders.

Main Methods:

• Utilized numerous fibroblast cell lines from patients with known OXPHOS deficiencies.
• Developed experimental protocols for direct cellular respiration analysis using the Seahorse XF96 apparatus.
• Measured oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) in 96-well plates.

Main Results:

• Microscale oxygraphy demonstrated higher sensitivity compared to spectrophotometry for evaluating cellular respiration.
• The Seahorse XF96 method proved to be more cost-effective and rapid for initial screening.
• Direct readout of cellular respiration in fibroblasts provided a viable method for detecting OXPHOS defects.

Conclusions:

• Microscale oxygraphy using the Seahorse XF96 is a superior first-level screening tool for suspected mitochondrial disorders.
• This approach overcomes limitations of traditional spectrophotometric assays regarding sensitivity and material requirements.
• The developed protocols enable efficient biochemical evaluation of OXPHOS deficiencies directly in cellular samples.